Kira Biotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Kira Biotech General Information

Description

Developer of immunomodulatory monoclonal antibody therapeutics designed for the treatment of immune system disorders. The company develops selective, immune-cell-depleting monoclonal antibody candidates that target activated pathogenic immune cells, induce sustained immune tolerance, preserve non-activated cells, and restore biological homeostasis through structured preclinical and clinical pipeline stages, enabling medical practitioners and clinical researchers to suppress destructive inflammatory responses and treat autoimmune diseases without triggering generalized systemic immune suppression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 3, 88 Jephson Street
  • Toowong, Queensland 4066
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Level 3, 88 Jephson Street
  • Toowong, Queensland 4066
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kira Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 17-Oct-2019 Completed Clinical Trials - Phase 1
To view Kira Biotech’s complete valuation and funding history, request access »

Kira Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Kira Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kira Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunomodulatory monoclonal antibody therapeutics designed for the treatment of immune system disorders. Th
Drug Discovery
Toowong, Australia
5 As of 2025

Westlake Village, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kira Biotech Competitors (1)

One of Kira Biotech’s competitors is Arcutis Biotherapeutics, a Formerly VC-backed company based in Westlake Village, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arcutis Biotherapeutics Formerly VC-backed Westlake Village, CA
You’re viewing 1 of 1 competitors. Get the full list »

Kira Biotech Patents

Kira Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021258140-A1 Cd83 binding protein conjugates for treating lymphoma Inactive 23-Jun-2020
AU-2020902090-A0 Combination therapy Pending 23-Jun-2020
AU-2018333275-A1 Treatment method Inactive 13-Sep-2017
AU-2022204077-A1 Treatment method Inactive 13-Sep-2017
EP-3681536-A1 Treatment method Inactive 13-Sep-2017 C07K16/2803
To view Kira Biotech’s complete patent history, request access »

Kira Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kira Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advance Queensland Government Minority
IP Group Australia Venture Capital Minority
OneVentures Venture Capital Minority
SPRIM Global Investments Holding Company Minority
To view Kira Biotech’s complete investors history, request access »

Kira Biotech FAQs

  • When was Kira Biotech founded?

    Kira Biotech was founded in 2019.

  • Where is Kira Biotech headquartered?

    Kira Biotech is headquartered in Toowong, Australia.

  • What is the size of Kira Biotech?

    Kira Biotech has 5 total employees.

  • What industry is Kira Biotech in?

    Kira Biotech’s primary industry is Drug Discovery.

  • Is Kira Biotech a private or public company?

    Kira Biotech is a Private company.

  • What is Kira Biotech’s current revenue?

    The current revenue for Kira Biotech is .

  • How much funding has Kira Biotech raised over time?

    Kira Biotech has raised $13.5M.

  • Who are Kira Biotech’s investors?

    Advance Queensland, IP Group Australia, OneVentures, and SPRIM Global Investments have invested in Kira Biotech.

  • Who are Kira Biotech’s competitors?

    Arcutis Biotherapeutics is a competitor of Kira Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process